Xenon Pharmaceuticals Inc. Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
  • Xenon Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $411K, a 1.23% increase year-over-year.
  • Xenon Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $1.62M, a 76.7% increase from 2022.
  • Xenon Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $919K, a 11.5% increase from 2021.
  • Xenon Pharmaceuticals Inc. annual Operating Lease, Payments for 2021 was $824K, a 30% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.62M +$705K +76.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $919K +$95K +11.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $824K +$190K +30% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $634K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $634K +$10K +1.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $624K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.